| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |